Gene | Gene name | Gene function | Tumor typea | Methodb | Clinical associationc | Samplesd | Methylation range (%) |
---|---|---|---|---|---|---|---|
APC | Adenomatous polyposis coli | Tumor suppression | HNSCC (Chen et al. 2007), SGC (Durr et al. 2010; Lee et al. 2010), NPC (Loyo et al. 2011) | MS-MLPA (Chen et al. 2007) QMSP (Durr et al. 2010; Loyo et al. 2011), MSP (Lee et al. 2010) | (HG,St,H) (Lee et al. 2010) | T (Chen et al. 2007; Durr et al. 2010; Lee et al. 2008; Loyo et al. 2011), MN (Durr et al. 2010; Lee et al. 2010) | 21–34 |
BLU | MYND-type containing 10 | Tumor suppression | NPC (Ayadi et al. 2008; Liu et al. 2003b; Loyo et al. 2011; Qiu et al. 2004) | QMSP (Loyo et al. 2011), MSP (Ayadi et al. 2008; Liu et al. 2003b; Qiu et al. 2004) | H (Ayadi et al. 2008) | T (Ayadi et al. 2008; Liu et al. 2003b; Loyo et al. 2011; Qiu et al. 2004), NE (Liu et al. 2003b; Qiu et al. 2004) | 34–74 |
CCNA1 | Cyclin A1 | Cell cycle | OSCC (Shaw et al. 2006) HNC (Tan et al. 2008; Tokumaru et al. 2004), NPC (Yanatatsaneejit et al. 2008) | PS (Shaw et al. 2006), BS (Tokumaru et al. 2004), QMSP (Tan et al. 2008) MSP (Yanatatsaneejit et al. 2008), COBRA (Yanatatsaneejit et al. 2008) | HG (Shaw et al. 2006) | T (Shaw et al. 2006; Tan et al. 2008; Tokumaru et al. 2004; Yanatatsaneejit et al. 2008), NE (Tokumaru et al. 2008; Yanatatsaneejit et al. 2008) MN (Shaw et al. 2006), SM (Tan et al. 2008), L (Yanatatsaneejit et al. 2008) | 45–53 |
CDH1 | E-cadherin | Cell adhesion | HNSCC (De Schutter et al. 2009; Hasegawa et al. 2002; Righini et al. 2007; Steinmann et al. 2009), HPC (Dikshit et al. 2007) SGC (Zhang et al. 2007a), OSCC (Chang et al. 2002; De Moraes et al. 2008; Maeda et al. 2007a; Viswanathan et al. 2003; Yeh et al. 2002) LC (Azarschab et al. 2003; Dikshit et al. 2007) NPC (Ayadi et al. 2008; Chang et al. 2003b; Kao et al. 2002; Krishna et al. 2005; Li et al. 2003a, b; Niemhom et al. 2008; Tsao et al. 2003; Wong et al. 2003b) | MSP (Ayadi et al. 2008; Azarschab et al. 2003; Chang et al. 2003b; Chang et al. 2002; De Moraes et al. 2008; De Schutter et al. 2009; Dikshit et al. 2007; Hasegawa et al. 2002; Krishna et al. 2005; Li et al. 2003a, b)MSP (Maeda et al. 2007a; Niemhom et al. 2008; Righini et al. 2007; Steinmann et al. 2009; Tsao et al. 2003; Wong et al. 2003b) MSP (Yeh et al. 2002; Zhang et al. 2007a), SRM-PCR (Viswanathan et al. 2003) BS (Kao et al. 2002) | (B-LRC, B-S) (De Schutter et al. 2009) (B-DFS,B-DSS, B-O) (De Schutter et al. 2009), (TU,St,TS) (Hasegawa et al. 2002) MET (Azarschab et al. 2003; Li et al. 2003a), (PD,PI) (Zhang et al. 2007a) LNM (Ayadi et al. 2008; De Moraes et al. 2008; Li et al. 2003b), I (Li et al. 2003a) EBV (Kao et al. 2002; Krishna et al. 2005; Li et al. 2003a; Niemhom et al. 2008; Tsao et al. 2003) St (Niemhom et al. 2008) | M-SA (Hasegawa et al. 2002; Righini et al. 2007), NE (Chang et al. 2003b; Niemhom et al. 2008; Tsao et al. 2003) MN (Righini et al. 2007; Steinmann et al. 2009; Viswanathan et al. 2003; Yeh et al. 2002) SA-H (Righini et al. 2007) LN (Chang et al. 2002; Li et al. 2003a; Li et al. 2003b) T (Ayadi et al. 2008; Azarschab et al. 2003; Chang et al. 2002, 2003b; De Moraes et al. 2008; De Schutter et al. 2009; Dikshit et al. 2007; Hasegawa et al. 2002; Kao et al. 2002; Krishna et al. 2005; Li et al. 2003a) T (Li et al. 2003b; Maeda et al. 2007a; Niemhom et al. 2008; Righini et al. 2007; Steinmann et al. 2009; Tsao et al. 2003; Viswanathan et al. 2003) T (Wong et al. 2003b; Yeh et al. 2002; Zhang et al 2007a) | 23–85 |
CHFR | Checkpoint with forkhead and ring finger domains | Early G2/M checkpoint | HNSCC (Chen et al. 2007; Yalniz et al. 2011) OSCC (Baba et al. 2009; Toyota et al. 2003), NPC (Cheung et al. 2005) | MS-MLPA (Chen et al. 2007; Yalniz et al. 2011) MSP (Baba et al. 2009; Cheung et al. 2005), MSRE (Toyota et al. 2003) | n.a. | T (Baba et al. 2009; Chen et al. 2007; Cheung et al. 2005; Toyota et al. 2003; Yalniz et al. 2011), MN (Baba et al. 2009; Toyota et al. 2003) NE (Baba et al. 2009; Cheung et al. 2005; Toyota et al. 2003) | 19–61 |
DAPK1 | Death-associated protein kinase 1 | Apoptosis | HNSCC (Chen et al. 2007; Hasegawa et al. 2002; Nayak et al. 2007; Righini et al. 2007; Rosas et al. 2001; Sanchez-Cespedes et al. 2000; Steinmann et al. 2009) OSCC (Ogi et al. 2002), SGC (Li et al. 2005), LC (Zhang and Kong 2004) LC-HPC (Dikshit et al. 2007), OPC (Calmon et al. 2007) NPC (Chang et al. 2003b; Fendri et al. 2009; Kong et al. 2006; Kwong et al. 2002; Wong et al. 2002) | MS-MLPA (Chen et al. 2007) QMSP (Nayak et al. 2007), MSRE (Ogi et al. 2002) MSP (Calmon et al. 2007; Chang et al. 2003b; Dikshit et al. 2007; Fendri et al. 2009; Hasegawa et al. 2002; Kong et al. 2006; Kwong et al. 2002; Li et al. 2005) MSP (Righini et al. 2007; Rosas et al. 2001; Sanchez-Cespedes et al. 2000; Steinmann et al. 2009; Wong et al. 2002; Zhang and Kong 2004), | (St,TS,TU) (Hasegawa et al. 2002) LNM (Calmon et al. 2007; Fendri et al. 2009; Hasegawa et al. 2002; Sanchez-Cespedes et al. 2000) St (Sanchez-Cespedes et al. 2000) | M-SA (Chang et al. 2003b; Hasegawa et al. 2002; Righini et al. 2007; Rosas et al. 2001) NE (Chang et al. 2003b; Kwong et al. 2002; Wong et al. 2002), M-SE (Sanchez-Cespedes et al. 2000) SA-H (Righini et al. 2007), CINT (Kong et al. 2006) MN (Fendri et al. 2009; Righini et al. 2007; Steinmann et al. 2009; Zhang and Kong 2004), (L) (Wong et al. 2002) T (Calmon et al. 2007; Chang et al. 2003b; Chen et al. 2007; Dikshit et al. 2007; Fendri et al. 2009; Hasegawa et al. 2002; Kong et al. 2006; Kwong et al. 2002; Li et al. 2005; Nayak et al. 2007; Ogi et al. 2002) T (Righini et al. 2007; Rosas et al. 2001; Sanchez-Cespedes et al. 2000; Steinmann et al. 2009; Wong et al. 2002; Zhang and Kong 2004) | 7–77 |
DCC | Deleted in colorectal cancer | Tumor suppression | OSCC (Kaur et al. 2010; Ogi et al. 2002), HNSCC (Carvalho et al. 2006; Tan et al. 2008), NPC (Loyo et al. 2011) | QMSP (Carvalho et al. 2006; Kaur et al. 2010; Loyo et al. 2011; Tan et al. 2008), BS (Ogi et al. 2002) | (I, P-S) (Ogi et al. 2002) | T (Carvalho et al. 2006; Kaur et al. 2010; Loyo et al. 2011; Ogi et al. 2002; Tan et al. 2008) SA-H (Carvalho et al. 2006; Kaur et al. 2010) SE-H (Kaur et al. 2010), NE (Kaur et al. 2010), SM (Carvalho et al. 2006; Tan et al. 2008) | 50–75 |
DLC1 | Deleted in liver cancer 1 | Tumor suppression | n.a. | T (Loyo et al. 2011; Seng et al. 2007), (MN,NE,SM) (Seng et al. 2007) | 43–89 | ||
DLEC1 | Deleted in lung and esophageal cancer | Tumor suppression | H (Ayadi et al. 2008) | 60–86 | |||
EDNRB | Endothelin receptor type B | Signaling mechanism | HNSCC (Demokan et al. 2010), OSCC (Kaur et al. 2010; Pattani et al. 2010), PM-OCL (Pattani et al. 2010), NPC (Lo et al. 2002; Zhou et al. 2007) | QMSP (Demokan et al. 2010; Kaur et al. 2010; Pattani et al. 2010), MSP (Lo et al. 2002; Zhou et al. 2007) | H (Pattani et al. 2010) | T (Demokan et al. 2010; Kaur et al. 2010; Lo et al. 2002; Pattani et al. 2010; Zhou et al. 2007) SA-H (Demokan et al. 2010; Kaur et al. 2010; Pattani et al. 2010), SE-H (Kaur et al. 2010) NE (Kaur et al. 2010; Lo et al. 2002) | 60–97 |
HIN-1 | High-in-normal 1 | Tumor suppression | P-DFS (Huang et al. 2009) | T (Huang et al. 2009; Wong et al. 2003a), (NE, SA-H, L) (Wong et al. 2003a) | 7.3–77 | ||
hMLH1 | mutL homolog 1 | DNA repair | HNSCC (Demokan et al. 2006; Liu et al. 2002; Liu et al. 2003a; Puri et al. 2005; Sengupta et al. 2007; Steinmann et al. 2009; Zuo et al. 2009) PM-OCL (Sengupta et al. 2007) OSCC (Czerninski et al. 2009), NPC (Tan et al. 2006; Wong et al. 2003b) | MSP (Czerninski et al. 2009; Liu et al. 2003a; Puri et al. 2005; Steinmann et al. 2009; Tan et al. 2006) MSP (Wong et al. 2003b; Zuo et al. 2009) , MSRE (Demokan et al. 2006; Liu et al. 2003a; Sengupta et al. 2007) | H-MSI (Demokan et al. 2006; Sengupta et al. 2007; Zuo et al. 2009) P-S (Zuo et al. 2009) | MN (Sengupta et al. 2007; Steinmann et al. 2009; Zuo et al. 2009) NE (Czerninski et al. 2009) , T (Czerninski et al. 2009; Demokan et al. 2006; Liu et al. 2002, 2003a) T (Puri et al. 2005; Sengupta et al. 2007; Steinmann et al. 2009; Tan et al. 2006; Wong et al. 2003b; Zuo et al. 2009) | 32.5–50 |
hMSH2 | mutS homolog 2 | DNA repair | HNSCC (Demokan et al. 2006; Sengupta et al. 2007), PM-OCL (Sengupta et al. 2007) OSCC (Czerninski et al. 2009) | MSP (Czerninski et al. 2009), MSRE (Demokan et al. 2006; Sengupta et al. 2007) | n.a. | MN (Sengupta et al. 2007) , T (Czerninski et al. 2009; Demokan et al. 2010; Sengupta et al. 2007) ,NE (Czerninski et al. 2009) | 30–50 |
KIF1A | Kinesin family member 1A | Axonal transport of synaptic vesicles and cell division | HNSCC (Demokan et al. 2010; Hoque et al. 2008), OSCC (Kaur et al. 2010; Pattani et al. 2010), PM-OCL (Pattani et al. 2010), NPC (Loyo et al. 2011) | QMSP (Demokan et al. 2010; Hoque et al. 2008; Kaur et al. 2010; Loyo et al. 2011; Pattani et al. 2010) | T (Demokan et al. 2010; Hoque et al. 2008; Kaur et al. 2010; Loyo et al. 2011; Pattani et al. 2010) SA-H (Demokan et al. 2010; Kaur et al. 2010; Pattani et al. 2010), SE-H (Kaur et al. 2010) NE (Hoque et al. 2008; Kaur et al. 2010) | 35–98 | |
MGMT | O(6)-methylguanine-DNA methyltransferase | DNA repair | HNSCC (De Schutter et al. 2009; Hasegawa et al. 2002; Maruya et al. 2004; Puri et al. 2005; Righini et al. 2007; Rosas et al. 2001) HNSCC (Sanchez-Cespedes et al. 2000; Steinmann et al. 2009; Zuo et al. 2004) OSCC (Dikshit et al. 2007; Kato et al. 2006; Taioli et al. 2009; Viswanathan et al. 2003) PM-HNL (Maruya et al. 2004) , LC (Zhang et al. 2004, 2006) PC (Dikshit et al. 2007; Taioli et al. 2009), NPC (Wong et al. 2003b) | MSP (De Schutter et al. 2009; Dikshit et al. 2007; Hasegawa et al. 2002; Kato et al. 2006; Maruya et al. 2004; Puri et al. 2005) MSP (Righini et al. 2007; Rosas et al. 2001; Sanchez-Cespedes et al. 2000; Steinmann et al. 2009; Taioli et al. 2009) MSP (Wong et al. 2003b; Zhang et al. 2004, 2006; Zuo et al. 2004) SRM-PCR (Viswanathan et al. 2003) | (St, TS,TU) (Hasegawa et al. 2002), AU (Puri et al. 2005) (P-S, P-DFS) (Taioli et al. 2009) (I-RC,P-P) (Zuo et al. 2004) | M-SA (Hasegawa et al. 2002; Righini et al. 2007; Rosas et al. 2001) , M-SE (Sanchez-Cespedes et al. 2000) SA-H (Righini et al. 2007) MN (Kato et al. 2006; Maruya et al. 2004; Righini et al. 2007; Steinmann et al. 2009; Viswanathan et al. 2003; Zhang et al. 2004, 2006) NE (Zhang et al. 2004, 2006) T (De Schutter et al. 2009; Dikshit et al. 2007; Hasegawa et al. 2002; Kato et al. 2006; Maruya et al. 2004; Puri et al. 2005; Righini et al. 2007; Rosas et al. 2001) T (Sanchez-Cespedes et al. 2000; Steinmann et al. 2009; Taioli et al. 2009; Viswanathan et al. 2003; Wong et al. 2003b; Zhang et al. 2004, 2006; Zuo et al. 2004) | 6–56 |
MINT1 | Methylated in tumor-1 | Synaptic vesicle exocytosis | (ANS, P-P) (Ogi et al. 2002) | T (Durr et al. 2010; Ogi et al. 2002), MN (Durr et al. 2010) | 23–48 | ||
MINT31 | Methylated in tumor-31 | Tumor suppression | (St, P-P) (Ogi et al. 2002) | T (Carvalho et al. 2008; Ogi et al. 2002), NE (Carvalho et al. 2008) | 15–64 | ||
p14 | Alternative open reading frame (ARF) of INK4a locus | Tumor suppression | OSCC (Ishida et al. 2005; Kordi-Tamandani et al. 2010; Ogi et al. 2002; Sailasree et al. 2008; Shintani et al. 2001) HNSCC (Weber et al. 2002), PM-OCL (Takeshima et al. 2008) SGC (Nishimine et al. 2003) | MSRE (Ogi et al. 2002) MSP (Ishida et al. 2005; Kordi-Tamandani et al. 2010; Nishimine et al. 2003; Sailasree et al. 2008; Shintani et al. 2001; Takeshima et al. 2008; Weber et al. 2002) | G-P (Ogi et al. 2002; Sailasree et al. 2008), R-RC (Sailasree et al. 2008) (LNM,TS,St) (Ishida et al. 2005) | T (Ishida et al. 2005; Kordi-Tamandani et al. 2010; Nishimine et al. 2003; Ogi et al. 2002; Sailasree et al. 2008; Shintani et al. 2001; Takeshima et al. 2008; Weber et al. 2002) NE (Kordi-Tamandani et al. 2010; Takeshima et al. 2008) | 14–34 |
p15 | Cyclin-dependent kinase inhibitor 2B | Tumor suppression | OSCC (Ogi et al. 2002; Shintani et al. 2001; Viswanathan et al. 2003; Yeh et al. 2002), HNC (Chang et al. 2004) PM-OCL (Takeshima et al. 2008), NPC (Chang et al. 2003b; Wong et al. 2003b) | SRM-PCR (Viswanathan et al. 2003), MSRE (Ogi et al. 2002) QMSP (Chang et al. 2004) MSP (Chang et al. 2003b; Shintani et al. 2001; Takeshima et al. 2008; Wong et al. 2003b; Yeh et al. 2003) | MN (Viswanathan et al. 2003), M-SA (Chang et al. 2003b; Chang et al. 2004; Takeshima et al. 2008) NE (Chang et al. 2003b; Takeshima et al. 2008) T (Chang et al. 2003b; Chang et al. 2004; Ogi et al. 2002; Shintani et al. 2001; Takeshima et al. 2008; Viswanathan et al. 2003; Wong et al. 2003b; Yeh et al. 2003) | 22–65 | |
p16 | Cyclin-dependent kinase inhibitor 2A (CDKN2A) | Tumor suppression | OSCC (El-Naggar et al. 1997; González et al. 1997; Hall et al. 2008; Huang et al. 2002; Ishida et al. 2005; Kato et al. 2006; Kaur et al. 2010; Miracca et al. 1999; Nakahara et al. 2006) OSCC (Nakahara et al. 2001; Ogi et al. 2002; Ohta et al. 2009; Reed et al. 1996; Riese et al. 1999; Ruesga et al. 2007; Sailasree et al. 2008) OSCC (Shaw et al. 2006; Shintani et al. 2001; Sinha et al. 2009; Tao et al. 1997; Viswanathan et al. 2003; Yakushiji et al. 2001; Yeh et al. 2003) HNSCC (Ai et al. 2003; Carvalho et al. 2008; Hasegawa et al. 2002; Koscielny et al. 2007; Maruya et al. 2004; Okami et al. 2005; Puri et al. 2005) HNSCC (Righini et al. 2007; Rosas et al. 2001; Sanchez-Cespedes et al. 2000; Steinmann et al. 2009) PM-HNL (Cao et al. 2009; Hall et al. 2008; Kresty et al. 2002; Maruya et al. 2004; Takeshima et al. 2008), SGC (Agnese et al. 2006; Guo et al. 2007; Li et al. 2002; Nishimine et al. 2003), LC (Agnese et al. 2006; Dikshit et al. 2007; Smigiel et al. 2004) HPC (Dikshit et al. 2007), NPC (Chang et al. 2003b; Kwong et al. 2002; Lo et al. 1996; Tan et al. 2006; Wong et al. 2003b) | QMSP (Carvalho et al. 2008; Kaur et al. 2010; Tan et al. 2008) SRM-PCR (Viswanathan et al. 2003), PS (Hall et al. 2008; Shaw et al. 2006) SB (Reed et al. 1996), MSRE (El-Naggar et al. 1997; González et al. 1997; Miracca et al. 1999; Ogi et al. 2002; Tao et al. 1997) MSP (Agnese et al. 2006; Ai et al. 2003; Cao et al. 2009; Chang et al. 2003b; Dikshit et al. 2007; Hasegawa et al. 2002; Huang et al. 2002; Ishida et al. 2005; Kato et al. 2006; Kresty et al. 2002) MSP (Kwong et al. 2002; Li et al. 2005; Lo et al. 1996; Maruya et al. 2004; Nakahara et al. 2006; Nakahara et al. 2001; Nishimine et al. 2003) MSP (Ohta et al. 2009; Okami et al. 2005; Puri et al. 2005; Riese et al. 1999; Righini et al. 2007; Rosas et al. 2001; Rubin 2011; Ruesga et al. 2007; Sailasree et al. 2008; Sanchez-Cespedes et al. 2000) MSP (Shintani et al. 2001; Sinha et al. 2009; Smigiel et al. 2004; Steinmann et al. 2009; Takeshima et al. 2008; Tan et al. 2006) MSP (Weber et al. 2002; Wong et al. 2003b; Yakushiji et al. 2001; Yeh et al. 2003) | (A-TU,TU) (Hasegawa et al. 2002) (St, LNM,TS) (Hasegawa et al. 2002; Ishida et al. 2005) ANS (Kresty et al. 2002), PD (Steinmann et al. 2009) (I-RC, P-P) (Sailasree et al. 2008) | T (Agnese et al. 2006; Ai et al. 2003; Cao et al. 2009; Carvalho et al. 2008; Chang et al. 2003b; Dikshit et al. 2007; El-Naggar et al. 1997; González et al. 1997; Guo et al. 2007; Ha and Califano 2003; Hall et al. 2008; Hasegawa et al. 2002; Huang et al. 2002; Ishida et al. 2005) T (Kato et al. 2006; Kaur et al. 2010; Koscielny et al. 2007; Kresty et al. 2002; Kwong et al. 2002; Li et al. 2005; Lo et al. 1996; Maruya et al. 2004; Miracca et al. 1999; Nakahara et al. 2006) T (Nakahara et al. 2001; Nishimine et al. 2003; Ogi et al. 2002; Ohta et al. 2009; Okami et al. 2005; Puri et al. 2005; Reed et al. 1996) T (Riese et al. 1999; Righini et al. 2007; Rosas et al. 2001; Rubin 2011; Ruesga et al. 2007; Sailasree et al. 2008; Sanchez-Cespedes et al. 2000; Shaw et al. 2006; Shintani et al. 2001; Sinha et al. 2009; Smigiel et al. 2004; Steinmann et al. 2009) T (Takeshima et al. 2008; Tan et al. 2006, 2008; Tao et al. 1997; Viswanathan et al. 2003; Weber et al. 2002; Wong et al. 2003b; Yakushiji et al. 2001; Yeh et al. 2003) SA-H (Carvalho et al. 2008; Kaur et al. 2010; Righini et al. 2007) SE-H (Kaur et al. 2010), SM (Sinha et al. 2009; Tan et al. 2008) M-SA (Carvalho et al. 2008; Hasegawa et al. 2002; Righini et al. 2007; Rosas et al. 2001) NE (Carvalho et al. 2008; Chang et al. 2003b; Guo et al. 2007; Kaur et al. 2010; Kwong et al. 2002; Lo et al. 1996; Takeshima et al. 2008) M-SE (Carvalho et al. 2008; Nakahara et al. 2006; Sanchez-Cespedes et al. 2000) MN (Huang et al. 2002; Kato et al. 2006; Kresty et al. 2002) MN (Maruya et al. 2004; Miracca et al. 1999; Riese et al. 1999; Righini et al. 2007; Shaw et al. 2006; Steinmann et al. 2009; Viswanathan et al. 2003) | 5–68 |
PGP9.5 (UCHL1) | Ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase) | Processing of ubiquitin precursors and of ubiquitinated proteins | SGC (Durr et al. 2010), HNC (Tokumaru et al. 2004, 2008) OSCC (Tokumaru et al. 2008), NPC (Li et al. 2010; Loyo et al. 2011) | BS (Tokumaru et al. 2004), MSP (Li et al. 2010) QMSP (Durr et al. 2010; Loyo et al. 2011; Tokumaru et al. 2008) | n.a. | T (Durr et al. 2010; Li et al. 2010; Loyo et al. 2011; Tokumaru et al. 2004, 2008) MN (Durr et al. 2010) , NE (Tokumaru et al. 2004) | 60–82 |
RARß | Retinoic acid receptor beta | Tumor suppression | HNSCC (Chen et al. 2007; Maruya et al. 2004; Okami et al. 2005; Steinmann et al. 2009; Yalniz et al. 2011; Youssef et al. 2004) PM-HNL (Maruya et al. 2004), PM-OCL (Youssef et al. 2004) SGC (Durr et al. 2010), NPC (Fendri et al. 2009; Kwong et al. 2002; Kwong et al. 2005b) | MS-MLPA (Chen et al. 2007; Yalniz et al. 2011) MSP (Fendri et al. 2009; Kwong et al. 2005b; Kwong et al. 2002; Maruya et al. 2004; Okami et al. 2005) MSP (Steinmann et al. 2009; Youssef et al. 2004), QMSP (Durr et al. 2010) | (St, H) (Fendri et al. 2009) | MN (Durr et al. 2010; Fendri et al. 2009; Maruya et al. 2004; Steinmann et al. 2009) NE (Kwong et al. 2002; Youssef et al. 2004) T (Chen et al. 2007; Durr et al. 2010; Fendri et al. 2009; Kwong et al. 2002, 2005b; Maruya et al. 2004; Okami et al. 2005; Steinmann et al. 2009; Yalniz et al. 2011; Youssef et al. 2004) | 15–80 |
RASSF1A | Ras association (RalGDS/AF-6) domain family member 1A | Tumor suppression | HNSCC (Carvalho et al. 2008; Chen et al. 2007; Dong et al. 2003; Hasegawa et al. 2002; Okami et al. 2005; Righini et al. 2007; Steinmann et al. 2009), OSCC (Huang et al. 2009), SGC (Li et al. 2005), NPC (Chang et al. 2003b; Fendri et al. 2009; Kwong et al. 2002; Lo et al. 2001; Qiu et al. 2004; Tan et al. 2006; Wang et al. 2009; Wong et al. 2003b; Zhou et al. 2005) | MS-MLPA (Chen et al. 2007), QMSP (Carvalho et al. 2008) PCR-DHPLC (Huang et al. 2009) MSP (Chang et al. 2003b; Dong et al. 2003; Fendri et al. 2009; Hasegawa et al. 2002; Kwong et al. 2002; Li et al. 2005) MSP (Lo et al. 2001; Okami et al. 2005) (Qiu et al. 2004; Righini et al. 2007; Steinmann et al. 2009), MSP (Tan et al. 2006; Wang et al. 2009; Wong et al. 2003b; Zhou et al. 2005) | HPV (Dong et al. 2003) (St,TS,TU) (Hasegawa et al. 2002) (P-DFS) (Huang et al. 2009) (HG,St,MET) (Li et al. 2005) (LNM, A) (Fendri et al. 2009), EBV (Zhou et al. 2005) | M-SA (Chang et al. 2003b; Hasegawa et al. 2002; Righini et al. 2007) MN (Righini et al. 2007; Steinmann et al. 2009; Zhou et al. 2005) , SA-H (Righini et al. 2007) NE (Carvalho et al. 2008; Chang et al. 2003b; Dong et al. 2003; Fendri et al. 2009; Kwong et al. 2005b; Lo et al. 2001; Qiu et al. 2004; Wang et al. 2009) T (Carvalho et al. 2008; Chang et al. 2003b; Chen et al. 2007; Dong et al. 2003; Fendri et al. 2009; Hasegawa et al. 2002; Huang et al. 2009; Kwong et al. 2002; Li et al. 2005; Lo et al. 2001) T (Okami et al. 2005; Qiu et al. 2004; Righini et al. 2007; Steinmann et al. 2009; Tan et al. 2006; Wang et al. 2009; Wong et al. 2003b; Zhou et al. 2005) | 2.4–84 |
RASSF2 | Ras association (RalGDS/AF-6) domain family |member 2 | Tumor suppression | HNSCC (Steinmann et al. 2009) OSCC (Huang et al. 2009; Imai et al. 2008), NPC (Zhang et al. 2007b) | COBRA (Imai et al. 2008; Steinmann et al. 2009) PCR-DHPLC (Huang et al. 2009), MSP (Zhang et al. 2007b) | T (Huang et al. 2009; Imai et al. 2008; Steinmann et al. 2009; Zhang et al. 2007b), MN (Imai et al. 2008; Steinmann et al. 2009) NE (Zhang et al. 2007b) | 22–51 | |
SFRP1 | Secreted protein 1 | Inhibition of Wnt signaling | 24–58.6 | ||||
TIG1 | Tazarotene-induced gene-1 | Response to retinoic acid receptor | HNSCC (Tokumaru et al. 2005), NPC (Kwong et al. 2005a; Yanatatsaneejit et al. 2008) | MSP (Kwong et al. 2005a; Tokumaru et al. 2005) MSP-COBRA (Yanatatsaneejit et al. 2008) | n.a. | T (Kwong et al. 2005a; Tokumaru et al. 2005; Yanatatsaneejit et al. 2008), NE (Kwong et al. 2005a; Tokumaru et al. 2005; Yanatatsaneejit et al. 2008) L (Yanatatsaneejit et al. 2008) | 51–91 |
TIMP3 | Tissue inhibitor of metalloproteinases 3 | Inhibition of angiogenesis and tumor growth | HNSCC (De Schutter et al. 2009; Nayak et al. 2007; Righini et al. 2007), SGC (Durr et al. 2010) | MSP (De Schutter et al. 2009; Righini et al. 2007), QMSP (Durr et al. 2010; Nayak et al. 2007) | (B-LRC, B-S) (De Schutter et al. 2009) (B-DFS, B-DSS, B-O) (De Schutter et al. 2009) | T (De Schutter et al. 2009; Durr et al. 2010; Nayak et al. 2007; Righini et al. 2007), MN (Durr et al. 2010; Righini et al. 2007) M-SA (Righini et al. 2007), SA-H (Righini et al. 2007) | 40.5–71.8 |
WIF1 | Wnt inhibitory factor 1 | Inhibition of Wnt signaling | (TS, LNM) (Chan et al. 2007; Fendri et al. 2010) (MET, A) (Chan et al. 2007; Fendri et al. 2010) | 85–89.7 | |||
14-3-3 sigma | Stratifin | Signaling mechanism | SGC (Gasco et al. 2002; Uchida et al. 2004), OSCC (Gasco et al. 2002) PM-OCL (Gasco et al. 2002), NPC (Yi et al. 2009) | T (Gasco et al. 2002; Uchida et al. 2004; Yi et al. 2009), MN (Gasco et al. 2002; Yi et al. 2009) | 35–84 |